The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...

With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...

In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...

Novavax (NASDAQ:NVAX), and other vaccine developers extended recent gains on Tuesday as investors reacted to rising flu and ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Moderna shares soared as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu vaccine could ...

A statewide grand jury didn’t find evidence that COVID-19 vaccine manufacturers broke federal or state laws when making and ...

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you ...

The intervening years have both sped and crawled by, too busy at times to take stock of all that has changed, too plodding to ...

Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory ...